PATIENT CHARACTERISTICS AND TIME TO DISCONTINUATION OF DIFFERENT ANTI-HYPERGLYCEMIC MEDICATIONS FROM UK AND US ROUTINE CLINICAL CARE: A MULTI-DATABASE DESCRIPTIVE STUDY
Back
Abstract Number
WCN23-0441
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
PATIENT CHARACTERISTICS AND TIME TO DISCONTINUATION OF DIFFERENT ANTI-HYPERGLYCEMIC MEDICATIONS FROM UK AND US ROUTINE CLINICAL CARE: A MULTI-DATABASE DESCRIPTIVE STUDY
Co-authors
Vizcaya, D.(1)*;Lavallee, M.(2);Herrera, R.(3);James, G.(4);Kosareva, D.(2);Gay, A.(3);Golozar, A.(5);Oberprieler, N.(6);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Bayer, Pharmaceuticals, Sant Joan Despi, Spain;(2)Odysseus Inc, Data Science, Cambridge Ma, United States;(3)Bayer, Pharmaceuticals, Berlin, Germany;(4)Bayer, Pharmaceuticals, Reading, United Kingdom;(5)Odysseus, Data Science, Cambridge Ma, United States;(6)Bayer, Pharmaceuticals, Oslo, Norway;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/5fceb3d94634cd463ba0f473391b0f42.pdf
Audio File
if any